Tuesday 5 November 2024
 
»
 
»
Story

Bahrain withdraws diabetes drug

Manama, September 27, 2010

Products containing the diabetes drug Rosiglitazone have been ordered off Bahrain's shelves by the Health Ministry.

It follows reports in Europe that pharmaceutical products such as Avandaryl, Avandamet and Avandia damage the heart and blood circulation.

The Pharmacy and Drugs Control Directorate has ordered these products off the shelves and is advising customers to stop using them. – TradeArabia News Service

 


 




Tags: Bahrain | Avandia | Diabetes | Health Ministry |

More Health & Environment Stories

calendarCalendar of Events

Ads